FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HD4YNB0

Market Closed - BOERSE MUENCHEN 01:15:15 25/05/2024 am IST
1.28 EUR -61.45% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-85.60%
1 month-91.06%
Date Price Change
24/24/24 1.28 -61.45%
23/24/23 3.32 +22.96%
22/24/22 2.7 +30.43%
21/24/21 2.07 +27.78%
20/24/20 1.62 -2.41%

Real-time BOERSE MUENCHEN

Last update May 25, 2024 at 01:15 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD4YNB
ISINDE000HD4YNB0
Date issued 24/04/2024
Strike 43.72
Maturity Unlimited
Parity 4.17 : 1
Emission price 9.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 23.64
Lowest since issue 0.7
Spread 0.04
Spread %3.13%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus